References:

1. Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, et al. Clinical practice guidelines by the infectious diseases society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis. 2011;52(3):e18-55.

2. McConeghy KW, Bleasdale SC, Rodvold KA. The empirical combination of vancomycin and a β-lactam for Staphylococcal bacteremia. Clin Infect Dis. 2013;57(12):1760

3. Providence Health Care P&T Committee. Management of Staphylococcus aureus Bacteremia. June 2014.

4. MSH + UHN Antimicrobial Stewardship Program. Clinical Summary: S. aureus Bacteremia. Accessed May 18, 2016. http://www.antimicrobialstewardship.com/sites/default/files/aspsimplemessaging--staphylococcusaureusbacteremia.pdf

5. Blondel-Hill E and Fryters S. Bugs & Drugs 2012.

6. The Johns Hopkins POC-IT ABX Guide App ©2000-2013. The Johns Hopkins University.

7. The Sanford Guides to Antimicrobial Therapy App ©1969-2016. Antimicrobial Therapy, Inc.

8. Health PEI Antibiogram 2014

9. Ng JK, Schulz LT, Rose WE, Fox BC, Andes DR, et al. Daptomycin dosing based on ideal body weight versus actual body weight: comparison of clinical outcomes. Antimicrobial Agents and Chemotherapy. 2014;58(1):88.

10. Shank BR, Zimmerman DE. Demystifying Drug Dosing in Obese Patients. Bethesda, MD: American Society of Health-System Pharmacists; 2016:20-21.